Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Cysteine-based regulation of redox-sensitive Ras small GTPases
Samantha Messina1, Giovanna De Simone1, Paolo Ascenzi1
1Department of Science, Roma Tre University, Viale Guglielmo Marconi 446, I-00146, Roma, Italy.
Abstract:
Reactive oxygen and nitrogen species (ROS and RNS, respectively) activate the redox-sensitive Ras small GTPases. The three canonical genes (HRAS, NRAS, and KRAS) are archetypes of the superfamily of small GTPases and are the most common oncogenes in human cancer. Oncogenic Ras is intimately linked to redox biology, mainly in the context of tumorigenesis. The Ras protein structure is highly conserved, especially in effector-binding regions. Ras small GTPases are redox-sensitive proteins thanks to the presence of the NKCD motif (Asn116-Lys 117-Cys118-Asp119). Notably, the ROS- and RNS-based oxidation of Cys118 affects protein stability, activity, and localization, and protein-protein interactions. Cys residues at positions 80, 181, 184, and 186 may also help modulate these actions. Moreover, oncogenic mutations of Gly12Cys and Gly13Cys may introduce additional oxidative centres and represent actionable drug targets. Here, the pathophysiological involvement of Cys-redox regulation of Ras proteins is reviewed in the context of cancer and heart and brain diseases.
Insights
Reactive oxygen and nitrogen species (ROS and RNS) regulate Ras proteins, crucial in cancer development. Cysteine oxidation in Ras impacts its function, offering potential therapeutic targets for cancer and other diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ras small GTPases (HRAS, NRAS, KRAS) are key regulators of cellular processes and frequently mutated in human cancers.
- Ras proteins are redox-sensitive, with their function modulated by reactive oxygen and nitrogen species (ROS and RNS).
Purpose of the Study:
- To review the pathophysiological role of cysteine redox regulation in Ras proteins.
- To highlight the involvement of Ras redox biology in cancer, heart, and brain diseases.
Main Methods:
- Literature review focusing on Ras protein structure, function, and redox-sensitive cysteine residues.
- Analysis of the impact of ROS/RNS on Ras protein stability, activity, localization, and interactions.
- Examination of oncogenic mutations affecting Ras cysteine residues as potential drug targets.
Main Results:
- The NKCD motif (Asn116-Lys117-Cys118-Asp119) is critical for Ras redox sensitivity, with Cys118 oxidation affecting protein properties.
- Additional cysteine residues (80, 181, 184, 186) also contribute to Ras modulation.
- Specific oncogenic mutations (Gly12Cys, Gly13Cys) create new oxidative centers, presenting actionable therapeutic opportunities.
Conclusions:
- Cysteine redox regulation is a critical mechanism influencing Ras protein function in health and disease.
- Targeting Ras cysteine oxidation holds promise for novel therapeutic strategies in oncology and other diseases.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
06:10Assessment of Cellular Oxidation using a Subcellular Compartment-Specific Redox-Sensitive Green Fluorescent Protein
Published on: June 18, 2020
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Balancing Redox Equations
Redox Reactions